Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin versus methylprednisolone in acute traumatic spinal cord injury
2007-004358-10Phase 3Completed
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of erythropoietin and methylprednisolone in spinal cord injury (SCI) (2 arms), sponsored by ASST Grande Ospedale Metropolitano Niguarda. Primary endpoint: Primary efficacy endpoint. Started Nov 2007; status: completed.
02
Drugs
erythropoietinmethylprednisolone
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on 2007-004358-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004358-10.